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An efﬁcient and fast method based on isopropyl 2-[(isopropoxycarbothiolyl)disulfanyl] ethane thioate
(IICDET) were used for the speciation and determination of trace amount of Cr(III and VI) in human
biological samples by cloud point assisted dispersive ionic liquid eliquid microextraction (CP-DILLME).
Cr(VI) has carcinogenic effects, so, speciation of chromium in human body such as blood cells is very
important. The cloudy solution was achieved by the mixture of acetone and IL ([C8MIM][PF6]) in human
blood samples containing Cr(III) ions that were already complexed by IICDET at pH 4.5. After reduction
Cr(VI) to Cr(III) by ascorbic acid, chromium speciation was obtained based on total chromium deter-
mination by electro thermal atomic absorption spectrometry (ET-AAS) and difference between total Cr
and Cr(III) content. In addition, Cr speciation in human blood cells was calculated based on IICDET/CP-
DILLME and hematocrit blood test (HCT). After optimized conditions, the enrichment factor (EF),
Linear range and limit of detection (LOD) was obtained 25.2, 0.02e1.75 mg L1 and 5.4 ng L1 in human
biological samples respectively. The validation of methodology was achieved by certiﬁed reference
material (CRM) and ICP-MS technique.
© 2016 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Recently, heavy metals get distinguished from other toxic pol-
lutants which, due to their non-biodegradability can accumulate in
living tissues, thus becoming concentrated throughout the food
chain and can be readily absorbed by the human body. Even a very
small amount of them can cause severe physiological or neuro-
logical damage to the human body. Chromium is a major pollutant
for the environment, usually as a result of some industrial pollution
including tanning factories, steelworks, industrial electroplating
and wood preservation. Among the elements that currently need to
be determined in environmental and pharmaceutical products,
chromium is important in view of some health risks such as chro-
mosomal aberration, mutations, carcinogenicity, andnd Environment, RIPI, Tehran,
hirkhanloo).
n open access article under the CCtransformation in cultured cells and a variety of DNA lesions [1e3].
Chromium species exist mainly in two different oxidation states
in the environment, Cr(III) and Cr(VI), which have contrasting
physiological effects. Cr(III) compounds play an important role in
the metabolism of glucose and certain lipids; in addition, it is
considered an essential trace element for the maintenance of an
effective protein metabolism in humans [4e6]. On the contrary, the
Cr(VI) toxic and carcinogenic effects present are due to their strong
oxidation potential and their relatively small size, which enables
them to penetrate through biological cell membranes, providing
damage to macromolecules such as proteins and DNA. Cr(VI) in-
hibits the enzymatic sulfur uptake of the cell and is also harmful to
lungs, liver and kidneys [7e9].
Chromium can enter the human body through breathing or
drinking water, and the level of it in the air, water and biological
samples is very low. Chromium concentration in drinking water is
generally less than 2 mg L1 [10]. The World Health Organization
(WHO) states that the guideline values of 50 mg L1 Cr(VI) are
considered to be too high as compared to its genotoxicity, and theBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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normal chromium levels found in blood are 0.1e1.7 mg L1 and
0.24e1.8 mg L1 in urine [11e13]. Cr(VI) compounds, once inside the
bloodstream, are actively transported into red blood cells (RBC) via
nonspeciﬁc anionic channels and then rapidly reduced to Cr(III)
which becomes bound to hemoglobin in RBCs
(Cr6þ/Cr5þ/Cr4þ/Cr3þ). Therefore, chromium levels in the red
blood cells indicate exposure to Cr(VI) and can be changed to Cr(III)
within these cells [14]. The reactive species produced by the
reduction of Cr(VI), particularly Cr(III), can form both ionic and
coordinate covalent complexes with DNA as inter strand cross-links
(DNA-Cr-DNA). In order to provide a timely warning of chromium
exposure, it is highly desirable to develop suitable procedures for
chromium speciation.
Sensitive techniques for determination of chromium species
include ion chromatography, inductively coupled plasma mass
spectrometry [15], luminescence quenching [16], stripping vol-
tammetry [17], co-precipitation [18,19], ﬂame atomic absorption
spectrometry (F-AAS) [20], neutron activation analysis (NAA) [21],
inductively coupled plasma optical emission spectrometry (ICP-
OES) [22,23], inductively coupled plasma-mass spectrometry (ICP-
MS) [24], ion chromatography inductively coupled plasma-mass
spectrometry (IC- ICP-MS) [15] and electrothermal atomic ab-
sorption spectrometry (ETAAS) [25,26] analysis techniques that
were frequently coupled with a prior preconcentration and/or
separation steps. However, the high instrumental and operational
costs and the high detection limits are common disadvantages of
many of these methods. Sample preparation procedures such as
liquid-liquid extraction (LLE) [27,28], homogeneous liquid-liquid
extraction [29,30], solid phase extraction (SPE) [4,31], liquid-
phase microextraction (LPME) [32] and cloud point extraction
(CPE) [33] are developed to simplify analytical approaches as it
reduces costs.
Dispersive liquid-liquid micro-extraction (DLLME) is a minia-
turization of the traditional LLE technique, where the extraction
phase is a drop of a few microlitres of a water-immiscible solvent
that can be directly immersed in the sample and dispersed by
organic solvent. Although organic solvents (i.e., octanol, cyclo-
hexane, and toluene) are useful as extraction phase, recently the
use of ionic liquids (IL) has been proposed in LLE. They have various
advantages over traditional organic solvents, such as low vapour
pressure, high stability, large viscosity, adjustable miscibility and
polarity, good extractability for different organic and inorganic
compounds [34e37].
Cloud point extraction (CPE) utilizes the clouding behavior of a
solution that containing a nonionic surfactant is heated before
being allowed to settle. Because the surfactant is dehydrated during
the settling process, the liquid separates into aqueous and
surfactant-rich phases. The cloud point phenomenon has been used
in separation science for extraction, puriﬁcation and preconcen-
tration [38,39].
The aim of this work is speciation of Cr(III) and Cr(VI) in human
blood cells, whole blood and serum samples (35 exposed subjects
and 35 unexposed controls) based on IICDET by CP-DLLME.
Experimental parameters affecting the extraction process were
optimized and the performance of the proposed method was
evaluated.
2. Materials and methods
2.1. Apparatus
Determination of chromium was performed with a spectra GBC
electro-thermal atomic absorption spectrometer (ET-AAS, Plus 932,
Australia) using a graphite furnace module (GF3000, GBC). Theoperating parameters for the metal of interest were set as recom-
mended by the manufacturer. A hollow cathode lamp (GBC) oper-
ating at a current of 6 mA and a wavelength of 357.9 nm with a
spectral bandwidth of 0.2 nm was used. The working range, mode
and volume injection have obtained 0.5e45 mg L1, Peak Area and
20 mL, respectively. The pH values of the solutions were measured
by a digital pH meter (Metrohm 744). A micro-hematocrit instru-
ment (Jouan, Italy, A13-HCT) was used for determination of the
ratio of blood cells/serum (HCT %) in whole blood samples. Induc-
tivity coupled plasma mass spectrometry (ICP-MS) was used for
determination of ultra-trace chromium in standard and human
blood samples (Perkin Elmer, QP, Elan6000 DRC, RIPI, Iran).2.2. Reagents and materials
All reagents with ultra-trace analytical grade were purchased
from Merck Germany. Iodine, dichloromethane (CH₂Cl₂), dithio-
carbomate (CH2NS2), sodium thiosulfate (Na2S2O3), magnesium
sulfate (MgSO4) and hexane (C₆H₁₄) were prepared from Merck.
Cr(III) stock solution was prepared from an appropriate amount of
the nitrate salt of this analyte as 1000 mg L1 solution in
0.01 mol L1 HNO3 (Merck). Cr(VI) stock solution was prepared
from an appropriate amount of the 1 g of Potassium salt (K2CrO4) of
this analyte as 1000 mg L1 solution in 1% HCl. Standard solutions
were prepared daily by dilution of the stock solution. The pH ad-
justments were made using appropriate buffer solutions including
sodium phosphate (H3PO4/NaH2PO4, 0.1 mol L1) for pH 2e3,
ammonium acetate (CH3COOH/CHCOONH4, 0.1 mol L1) for pH
4e6, sodium borate (NaBO2/HCl, 0.1 mol L1) for pH 7, and
ammonium chloride (NH3/NH4Cl, 0.1 mol L1) for pH 8e10 (Merck).
Polyoxyethylene octyl phenyl ether (TX-100, CAS N: 9036-19-5) as
the anti-sticking agent was purchased from Merck. Ultra-pure
lithium heparin (H0878, CAS N: 9045-22-1, 100KU) and sodium
citrate (S4641, CAS N: 6132-04-3, 25 g) were purchased from
Sigma-Aldrich in Iran. Isopropyl 2-[(isopropoxycarbothioyl) disul-
fanyl] ethane thioate was synthesized and puriﬁed in RIPI labora-
tories (IICDET; (CH3)4 (CO)2 S4). Ultrapure water (18 MU cm) was
obtained from Millipore continental water system (Bedford, USA),
and 1-octyl-3-methylimidazolium hexaﬂuorophosphate was pre-
pared from Sigma Aldrich (Germany, C12H23N2$PF6, CAS N: 304680-
36-2, 5 g). Graduated micro centrifuge conical tubes with cap
(2e10 mL) were purchased from Sigma-Aldrich (Germany, Product
N: SIAL311GZ2F).2.3. Sampling
For sampling, all glass tubes were washed with a 0.5 mol L1
HNO3 solution for at least 24 h and thoroughly rinsed 6 times with
ultrapure water before use. As chromium concentrations in whole
blood and serum are very low, even minor contamination at any
stage of sampling, sample storage and handling, or analysis has the
potential to affect the accuracy of the results. Heparin is commonly
used as anticoagulants in human blood samples. The blood
collection tube with heparin was aliquoted into Eppendorf tubes
(5 mL) and kept at20OC for oneweek. For analysis inwhole blood,
10 mL of pure heparin (free chromium) is added to a 10 mL blood
sample of painting workers from Iranian car factory, Tehran, Iran.
Hematocrit percentage (HCT %) was determined by centrifuging
heparinized blood in a capillary tube (micro-hematocrit tube) at
10,000 rpm for 8 min. The human blood sample was maintained
at 20 C in a cleaned glass tube. Serum and blood samples were
collected from exposed (35) and unexposed (35) subjects from
Iranian car factory between 20 and 45 years of age.
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ethanethioate (IICDET)
A solution of potassium O-isopropyl (dithiocarbamate)
(1 mmol) in 20 mL of water was cooled in an ice bath; then a so-
lution of iodine (1 mmol) and potassium iodide (1 mmol) in water
(20 mL) was added dropwise. After stirring for 1 h, the aqueous
phase was extracted with CH2Cl2 (3  10 mL), washed with 30 mL
of 10% aqueous Na2S2O3 and then with 30 mL of de-ionized water.
The organic layer was dried with anhydrous calcium chloride and
evaporated under vacuum. Further puriﬁcation was achieved by
recrystallization in hexane. A pale yellowish crystal of IICDETwith a
yield of 90% was obtained. The structure and purity of IICDET were
conﬁrmed by NMR and IR spectroscopic methods (Figs. 1e3). 1H
NMR (CDCl3). d (ppm): 1.43 (d, 12H, CH3), 5.63 (m, 2H, CH). 13C NMR
(CDCl3). d (ppm): 22.2, 80.6, 207.1. IR (KBr). nmax (cm1): 2979.8
(s), 2869.9 (w), 1463.9 (s), 1442.7 (s), 1373.0 (s), 1271.1 (s, b), 1145.6
(s), 1082.2 (s), 1048.0 (s, b) 898.8 (s), 796.5 (s), 690. 5 (m).
2.5. General procedure
A pre-concentration procedure based on IICDET by CP-DILLME
was performed as follows: ﬁrst, 0.15  106 mol L1 of IICDET so-
lution as a ligand, 0.01 mL of triton X-100 (0.3% w/v) and a 1 mL
buffer solution (pH ¼ 4.5) were added to 5 mL of human blood
samples after dilution with DW up to 5 mL (1:5). Then, cloud point
extraction for Cr(III) ions was achieved by adding, 0.12 g (100 mL) of
IL ([C8MIM][PF6]) and 0.2 mL of acetone as a dispersive solvent to
blood samples. Triton X-100, an emulsiﬁer and anti-sticking agent,
was added to the solution in order to raise the efﬁciency of the
extraction procedure. For optimizing and recovery, 5 mL of 0.2 and
1.2 mg L1 Cr(III) working standard solution was used instead of the
blood and serum samples, and 0.12 g of 1-octyl-3-
methylimidazolium hexaﬂuorophosphate ([C8MIM][PF6])
dispersed in acetone, was added to standard sample with mixture
of IICDET, TX-100 and buffer solution. The cloudy solution was
shaken for 2 min by ultrasonic shaking at 25 OC. In order to separate
the phases, the turbid solution was centrifuged for 4 min at
3500 rpm and the aqueous phase was removed with a transfer
pipette. Cr(III) was back-extracted from IL by adding 0.2 mL of
1.2 mol L1 nitric acid and the aqueous phase was shaken for 1 min
and determined by ET-AAS. In the optimum pH conditions, total
chromium was calculated by reduction Cr(VI) to Cr(III) by ascorbic
acid solution (0.5 mL, 0.1 mol L1). Then, Cr(VI) concentration was
simply calculated by the difference between total chromium and
Cr(III) concentrations. By redox reaction of ascorbic acid, Cr(VI) is
reduced to Cr(III) and ascorbic acid is dehydrogenated to dehy-
droascorbic acid. The reaction can be described by the following
equation (1):
Cr2O7
2 þ 3C6H8O6 þ 8Hþ/2Cr3þ þ 3C6H6O6þ7H2O (1)
The blank solutions proceeded the same way and are used for
the preparation of the calibration solutions and for measurement of
the blanks. Chromium Speciation in blood cells was performed by
measuring HCT of blood sample and speciation of chromium in
serum and whole blood samples based on proposed procedure.
After speciation of chromium in blood and serum samples, level of
Cr(III,VI) concentrations in blood cells, were simply obtained by CP-Fig. 1. Isopropyl 2-[(isopropoxy carbothioyl) disulfanyl] ethanethioate (IICDET).DILLME method. The extraction conditions in IICDET/CP-DILLME
method is listed in Table 1.3. Results and discussion
The proposed method based on IICDET with CP-DILLME was
used for chromium speciation in standard solution and human
biological matrix (Whole blood, serum and Blood cells) with
appropriate accuracy and precision. The results showed us, the
mean concentrations of Cr(III and VI) in blood samples of exposed
subjects (35 N) were signiﬁcantly higher than unexposed controls
respectively [(0.59 ± 0.13 mg/L, 0.27 ± 0.11 mg/L) and (1.29 ± 0.81 mg/
L, 0.08 ± 0.05 mg/L)] and the most Cr (VI) and Cr(III) concentration
was existed in blood cells and serum respectively.
The recovery was deﬁned as the percentage of the total analyte
(CT) which was extracted into the ionic liquid phase (CIL) (2).
%R ¼ ðCIL=CTÞ  100

Ccoll
C0

 100 ¼
"
CcollVcoll
C0 Vaq
#
 100 (2)
3.1. Effect of ETAAS conditions
In order to increase the accuracy, precision and repeatability, we
have used Triton (TX-100) in 25 C. The one step of temperature
program is a drying temperature (125 C) with time of 20 s for
water evaporation. Then, a long ramp time of 50 s was chosen as it
allowed gradual elimination of trace organic ionic liquid from an-
alyte (600e750 C) and avoided chromium loss in this temperature.
The inﬂuence of pyrolysis temperature on the absorbance was
studied up to 1500 C. The maximum absorbance was achieved
within a range of 1000e1200 C. Therefore, 1100 C was selected as
the working pyrolysis temperature. The effect of atomization
temperature on chromium signal was studied within the range of
2200e2800 C, and the maximum signal was obtained at approx.
2500 C. Finally, the cleaning time and temperature of graphite
tube were ordered at 3 s and 2700 C, respectively. The argon ﬂow
rate was 300 mL min1 (Fig. 4).3.2. Effect of pH
The inﬂuence of sample pH on adsorption of Cr(III) ion on IICDET
was investigated using different pH from 1 to 12 for 0.1 mg L1 Cr(III)
as a lower limit of quantiﬁcation (LLOQ) and 1.5 mg L1 Cr(III) as
upper limit of quantiﬁcation (ULOQ). The complexation was
strongly conditioned by the pH of solutions and subsequently af-
fects extraction efﬁciency of the complex. The results show that the
highest extraction efﬁciency for Cr(III) was achieved in pH 3e5.5,
but the recovery values for Cr(VI) were below 5% in the this pH.
Thus, the procedure was applied to speciation of two forms of
chromium at pH 4.5 (Fig. 5).
The extraction mechanism of Cr(III) ions with IICDET was highly
depended to pH solution and complex formation between Cr(III)
ions and sulfur groups of IICDET. The sulfur groups can be depro-
tonated (SH) at wide range of pH. The extraction capacity of Cr(III)
at different pH values may be attributed to the afﬁnities of sulfur
groups of ligand for the cationic form of Cr 3þ existing at optimized
pH. In addition, the different anionic species of Cr(VI) at low and
high pH (pH ¼ 2 and pH > 8), namely HCrO4, CrO42 and Cr2O72 has
negatively charged and cannot be adsorbed by negative charge of
SHe group in optimized pH.
Fig. 2. 1H NMR of isopropyl 2-[(isopropoxy carbothioyl) disulfanyl] ethanethioate (IICDET).
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The concentration of isopropyl 2-[(isopropoxycarbothiolyl)
disulfanyl]ethane thioate (IICDET) is one of the important param-
eters which should be optimized by CP-DLLME method. For opti-
mizing, 0.1 107e 0.5 106 mol L1 of IICDET ligand was used in
human blood sample by proposed procedure. The results showed
that, by increasing ligand concentration up to 0.5  106 mol L1,
the recoveries are also increased. Fig. 6 shows that
0.12  106 mol L1 of IICDET was the minimum ligand concen-
tration necessary to achieve maximum extraction efﬁciency. The
signal remained constant from 0.015  106 mol L1 up to at least
0.1  106 mol L1 IICDET for 0.2 mg L1 of Cr(III) as a LLOQ range.
Therefore, 0.2  107 mol L1 of IICDET concentrationwas selected.
For 1.75 mg L1 of Cr(III) as a ULOQ range, the signal remained
constant from 0.12  106 mol L1 up to at least 0.5  106 mol L1
and 0.15  106 mol L1 was selected as an optimized ligand con-
centration. The minimum buffer concentration required to adjust
the pH 3e5.5 and to achieve the best performance of the extraction
system was 0.15e0.25 mol L1.3.4. Effect of sample volume and amount of ionic liquid
Sample volume is one of the most important parameters to be
studied. The effect of sample volume was examined in different
volumes from 1 to 20 mL for 0.2 mg L1 and 1.5 mg L1 of Cr(III).
Quantitative extraction was observed between 1 and 10 mL. At
higher volumes the recoveries are decreased. It was also noticedthat higher sample volumes partially solubilized the ionic liquid
phase, leading to non-reproducible results. Therefore, a sample
volume of 5 mL was selected for further experiments with IICDET -
CP-DLLME method (Fig. 7).
It was observed that extraction efﬁciency of the system was
remarkably affected by ionic liquid amount, so it was examined
within the range of 0.03e0.2 g. Quantitative extraction was
observed at higher than 0.1 g. Therefore, in order to achieve a
suitable preconcentration, 0.12 g of ionic liquid ([C8MIM][PF6]) was
chosen as optimum leading to a ﬁnal IL (Fig. 8).3.5. Effect of various mineral acids on back-extraction of ionic liquid
phase
Direct injection of ionic liquids into ETAAS was not possible,
because ILs have high viscosity. The proposedmethodwas achieved
based on back-extraction of chromium from IL with a mineral
acidic/basic solution. Therefore, decreasing/increasing of pH, leads
to dissociation and releasing of chromium ions into the aqueous
phase (mineral acidic/basic solution). Different concentration of
mineral reagents from 0.2 e2 mol L1 (HCl, HNO3, H2SO4, KOH)
were studied for chromium back-extraction from extracting phase
(Fig. 9). The results showed that 0.5 mol L1 of HNO3 at 70OC can be
back extracted Cr(III) from the IL phase (Fig. 10). After extraction of
Cr(III) ions by procedure, 0.2 mL of 0.5 mol L1 of HNO3 was added
in ultrasound batch (1 min, 70 OC) and Cr(III) ions back-extracted
from ionic liquid phase to liquid solution, then centrifuging for
2 min and the result solution adjusted to 0.2 mL with DW in micro
Fig. 3. 13C NMR of isopropyl 2-[(isopropoxy carbothioyl) disulfanyl] ethanethioate (IICDET).
Table 1
Chromium extraction conditions in IICDET/CP-DLLME method.
Parameters Value
pH 4.5
IICDET Conc.(mol L1) 0.15  106
Volume of Buffer (mL) 1.0
Concentration of HNO3 (mol L1) 0.5
IL(g) 0.12
Volume of Acetone (mL) 0.2
Shaking time (min) 2.0
Centrifugation time (min) 4.0
Sample volume (mL)a 5
a 5 mL of standard solution and 1 mL of blood samples diluted up to 5 mL
with DW (1:5).
Fig. 4. Pyrolysis and atomization temperature curves obtained by 20 mL injection of a
1 mg L1 Cr III solution in presence of HNO 2%. Atomization temperature for pyrolysis
H. Shirkhanloo et al. / Analytical Chemistry Research 10 (2016) 18e2722centrifuge conical tube (2 mL, graduated tube) before determining
by ET-AAS with auto sampler.3
optimization: 2500 C. Pyrolysis temperature for atomization optimization: 1100 C.
(95% conﬁdence interval; n ¼ 5).3.6. Effect of ultrasound-assisted extraction time
The optimization of ultrasonication time is crucial to achieve an
efﬁcient IICDET/CP-DLLME procedure. In this study, different
ultrasound-assisted extraction times ranging from 30 to 240 s was
evaluated for proposed procedures, respectively. As shown in
Fig. 11, by increasing the ultra-sonication time the relative response
increases, reaching the maximumvalue at 110 s and then remained
constant. Therefore, the ultrasonic times of 2 min for ligand
complexation (IICDET) before cloudy solution and 1 min for back-extraction of Cr(III) from IL with HNO3 were employed.3.7. Effect of matrix
ETAAS is a very speciﬁc technique with low sensitivity to
interference. Then, the potential interference effects occurring in
this procedure are mainly related to the extraction during the pre-
Fig. 5. Optimization of conditions for Cr(III) extraction. The inﬂuence of pH on Cr III e
IICDET extraction in blood and water.
Fig. 6. The inﬂuence of IICDET concentration on Cr(III) recovery. Other conditions was
as indicated in Table 1 (95% conﬁdence interval; n ¼ 5).
Fig. 7. The inﬂuence of sample volume on Cr recovery by application of the proposed
procedure based on IICDET/CP-DLLME. Other conditions were as indicated in Table 1
(95% conﬁdence interval; n ¼ 5).
Fig. 8. The inﬂuence of amount of ionic liquid on Cr recovery by application of the
proposed procedure. Other conditions of IICDET/CPeDLLME were as indicated in
Table 1 (95% conﬁdence interval; n ¼ 5).
Fig. 9. The inﬂuence of different reagents on back extraction of chromium by proposed
method. Other conditions were as indicated in Table 1 (95% conﬁdence interval; n ¼ 7).
Fig. 10. The inﬂuence of nitric acid concentration in different temperature for back
extraction of chromium from IL by proposed method. Other conditions were as indi-
cated in Table 1 (95% conﬁdence interval; n ¼ 7).
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samples of interest, the most probable metal ions' reported effect of
potential interfering ions on the determination of chromium were
investigated. The procedure of CP-DLLME was performed using a
5 mL sample containing 1.5 mg L1 of analyte and 0.2e12 mg L1
different concentration of matrix ions. The tolerate amounts of each
ionwere the concentration values tested that caused less than 5% of
the absorbance alteration. The ions normally present in the sample
do not interfere under the experimental conditions used. Theresults are shown in Table 2.3.8. Analytical ﬁgures of merit
Analytical parameters, such as linear range, correlation coefﬁ-
cient, limits of detection, accuracy and precision were evaluated by
preconcentrating 5 mL of human biological samples and standard
solutions (pH ¼ 4.5) containing listed ions. The calibration curve of
human biological samples and standard solutions was rectilinear in
the range of 0.02e1.75 mg L1 and 0.02e1.80 mg L1, respectively as
a lower limit of quantiﬁcation (LLOQ) and upper limit of
Fig. 11. The inﬂuence of ultrasound time with ligand mass on high recovery of Cr(III)
by application of the proposed procedure (Mean recoveryz98%). Other conditions of
IICDET/CPeDLLME were as indicated in Table 1 (95% conﬁdence interval; n ¼ 7).
Table 2
The effect of matrix ions on the determination of Cr(III) by IICDET method (mg L1).
Ions Maximum tolerance ratio
(matrix ion conc./Cr conc.)
Naþ, Kþ, Ba2þ, Mg2þ, Ca2þ, As3þ, Co2þ, Al3þ, Mn2þ 6500
Hg2þ, Au3þ 200, 300
As5þ, PO43, Cl, CO32, SO42, NO3, F 7200
Fe3þ and Fe2þ 2800
Agþ, Pb2þ 250,500
Zn2þ, Cu2þ 1200
Ni2þ 400
This work was performed using 5 mL of 1.5 mg L1 Cr standard solution.
Table 3
Speciation of chromium in serum, blood and blood cells by IICDET/CPeDLLME method (s
determinations of samples ± conﬁdence interval (P ¼ 0.95, n ¼ 10).
Sample Subjects (n ¼ 35)
CrIII CrVI
Serum (mg L1) 1.06 ± 0.77 0.08 ± 0.04
Blood Cells (mg L1) 0.07 ± 0.03 1.25 ± 0.69
Blood (mg L1) 0.59 ± 0.13 1.29 ± 0.81
a Correlations are based on Pearson coefﬁcients (r). Statistical signiﬁcance will be obs
Table 4
Validation of chromium speciation based on IICDET/CPeDLLME with standard addition i
Sample Added (mg L1) Found (mg L1)
Cr (III) Cr (VI) Cr (III)
Whole Blood e e 0.662 ± 0.026
0.3 e 0.964 ± 0.048
e 0.2 0.664 ± 0.028
Whole Blood e e 1.002 ± 0.055
0.5 e 1.477 ± 0.073
e 0.2 0.981 ± 0.041
Whole Blooda e e 0.172 ± 0.009
0.5 e 0.645 ± 0.031
e 0.5 0.165 ± 0.011
Serum e e 0.655 ± 0.033
0.5 e 1.137 ± 0.062
e 0.2 0.653 ± 0.036
Serum e e 1.141 ± 0.058
0.5 e 1.624 ± 0.077
e 0.2 1.138 ± 0.061
Mean of three determinations ± conﬁdence interval (P ¼ 0.95, n ¼ 5).
a Whole Blood (WB) diluted with DW (1:5), the concentration is out of linear range, F
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relative standard deviation) was evaluated for target analyte. The
detection limits were calculated as the concentration providing an
analytical signal three times higher than the background noise. The
limit of detection (LOD) was obtained 5.4 ng L1 and 4.6 ng L1 for
5 mL of human and standard samples, respectively (intra-day,
Mean of LOD¼ 5 ng L1). The precision of the method, expressed as
relative standard deviation (RSD %), was calculated from seven in-
dividual standards. The RSD (%) of chromium (III) standard solution
in different concentrations of 0.02, 0.5 and 1.5 mg L1 were obtained
4.7, 3.5 and 2.9, respectively (intra-day, mean of RSD% ¼ 3.8). The
preconcentration factor, calculated as the ratio of the concentration
of analyte after preconcentration to that prior preconcentration,
was obtained 24.5 and 25.2 for standard and human samples,
respectively (intra-day analysis, Mean of PF ¼ 25).
3.9. Method validation
The IICDET/CP-DLLME method was applied to determine Cr(VI)
and Cr(III) found as a base value in 5 mL of 35 exposed and control
subjects in human serum blood samples (Table 3). The mean con-
centration of Cr(III) was higher than Cr(VI) in serum subjects, but
the mean concentration of Cr(III) in blood samples was lower
concentration. The coloration analysis was achieved between Cr(III)
and Cr(VI) in subject and control group and there was a correlation
(r > 0.3) and regression between Cr(VI) and Cr(III) in blood subjects.
The weak correlation (rz 0.1) in serum and blood cells of exposed
subjects were observed. In addition, in control group, no correlation
and regression were shown between Cr(VI) and Cr(III) in human
samples. The spiked serum and whole blood were prepared toamples analyzed in inter day by blood and serum samples at 20 C) Mean of three
Controls (n ¼ 35) Subjecta
CrIII CrVI r P value
0.56 ± 0.22 0.04 ± 0.02 0.116 ¼0.02
0.05 ± 0.02 0.06 ± 0.04 0.072 <0.001
0.27 ± 0.11 0.08 ± 0.05 0.388 <0.005
erved if P < 0.05.
n human serum and blood samples by ET-AAS.
Total Recovery (%)
Cr (VI) Cr (III) Cr (V)
0.094 ± 0.003 0.756 ± 0.028 e e
0.101 ± 0.004 1.065 ± 0.056 101 e
0.289 ± 0.013 0.953 ± 0.045 e 98
0.223 ± 0.021 1.225 ± 0.064 e e
0.214 ± 0.011 1.691 ± 0.078 95 e
0.420 ± 0.018 1.401 ± 0.065 e 98
1.102 ± 0.057 1.274 ± 0.069 e e
1.098 ± 0.047 1.743 ± 0.084 95 e
1.584 ± 0.075 1.749 ± 0.092 e 96
0.152 ± 0.006 0.807 ± 0.043 e e
0.161 ± 0.005 1.298 ± 0.071 96 e
0.348 ± 0.016 1.001 ± 0.048 e 98
0.086 ± 0.002 1.227 ± 0.064 e e
0.088 ± 0.003 1.712 ± 0.082 97 e
0.289 ± 0.012 1.427 ± 0.078 e 102
inal Cr conc. ¼ found Cr conc.  5 (dilution factor).
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Cr(III) and Cr(VI). The remaining aliquots were spiked with
increasing quantities of Cr(VI)and Cr(III) and analyzed by the
IICDET/CP-DLLME method (Table 4). The recovery of spiked sam-
ples is satisfactorily reasonable and was conﬁrmed using addition
method, which indicates the capability of the system in the deter-
mination of Cr(VI) and Cr(III) in human blood samples. The IICDET/
CP-DLLME method can be used for speciation and determination of
Cr(VI)and Cr(III) in cells of blood samples. Chromium levels in the
RBC indicate exposure to Cr(VI) and can be changed to Cr(III) within
these cells [14]. Thus, after determining and speciation of concen-
tration of chromium in whole blood and serum samples by pro-
cedure, the concentration of Cr(III and VI) in blood cells was simply
calculated (Table 5). For validation, total chromium in real whole
blood and blood cells samples prepared with microwave digestion
and determined by ICP-MS before/after spiked with standard Cr(VI)Table 5
Speciation and determination of Cr (VI) and Cr(III) in blood cells based on HCT/IICDET/C
Samples Serum (SB) CPeDLLME Total SB Whole blood (WB) CPeDLLME
Cr (III) Cr (VI) Cr (III) Cr (VI)
Sample 1 1.253 ± 0.052 0.133 ± 0.005 1.386 ± 0.056 0.742 ± 0.025 0.411 ± 0.0
Sample 2 1.121 ± 0.042 0.213 ± 0.014 1.334 ± 0.058 0.812 ± 0.029 0.644 ± 0.0
Sample 3 0.953 ± 0.038 0.062 ± 0.002 1.015 ± 0.061 0.541 ± 0.022 0.073 ± 0.0
Sample 4 0.781 ± 0.032 0.123 ± 0.006 0.904 ± 0.043 0.572 ± 0.028 0.183 ± 0.0
(1-HCT)  SB (Total Cr) e WB (Total Cr) ¼ BC (Total Cr).
Cr(VI)  BC¼ Cr(VI)  WB-[(1-HCT)  Cr(VI) SB].
Table 6
Comparing of ICPMS method and IICDET/CPeDLLME and HCT/IICDET/CPeDLLME metho
Sample ICP-MS (mg L1)
CrIII CrVI Total
Blood e e 0.752 ± 0.035
0.50 e 1.233 ± 0.037
e 0.50 1.241 ± 0.041
ICP-MS (mg L1)
Cr III Cr VI Total
Cells of blooda e e 0.517 ± 0.031
0.50 e 0.997 ± 0.044
e 0.50 1.022 ± 0.046
a Based on standard method, blood cell sample after centrifuging (blood separation fro
standard solution determined by ICP-MS.
Table 7
Comparison presented method with published reported method for speciation of Cr in b
Method Detection Measurability of Cr in RBC matrix
CPEc ETAAS No Human serum
SDMEd DRS-FTIRe No blood
TSIL-DLLMEf FAAS No water and urine samples
DSDMEg ETAAS No Water sample
DEMEh HPLC No Water sample
SFODMEi ETAAS No water and urine samples
SPE ETAAS No Water sample
IICDET/CPeDLLME ETAAS Yes Serum, whole blood, blo
a Preconcentration factor.
b Enrichment factor.
c Cloud point extraction.
d Single drop microextraction.
e Diffuse reﬂectance Fourier transform infrared spectroscopic.
f Task speciﬁc ionic liquid-based in situ dispersive liquideliquid microextraction.
g Directly suspended single droplet microextraction.
h Dual electromembrane extraction.
i Solidiﬁed ﬂoating organic drop microextraction.and Cr(III) solution. Also, the results of ICP-MS compared to IICDET/
CP-DLLME method. The results showed us, the high efﬁciency and
reliability of proposed method for determination and speciation of
Cr(VI) and Cr(III) in whole blood, blood cells samples (Table 6).4. Conclusions
In this research a new method based on IICDET/CP-DLLME was
used for the highly speciation and determination of trace amount of
Cr(III) and Cr(VI) in blood cells, whole blood and serum samples.
Factors inﬂuencing in IICDET/CP-DLLME were optimized. It pro-
vides a sensitive, efﬁcient, inexpensive and simple method for
speciation, preconcentration and separation of the chromium using
low sample volumes, which was compatible for handling of bio-
logical ﬂuids. The performance of this procedure for quantiﬁcation
of trace levels of chromium in blood samples was satisfactory. ThePeDLLME method by ET-AAS (mg L1).
Total WB Blood Cells (BC) HCT/CPeDLLME Total BC HCT (% ± 0.2)
Cr (III) Cr (VI)
19 1.153 ± 0.048 0.053 ± 0.002 0.340 ± 0.015 0.391 ± 0.017 45
27 1.456 ± 0.061 0.207 ± 0.013 0.529 ± 0.026 0.736 ± 0.028 46
03 0.614 ± 0.030 0.045 ± 0.002 0.041 ± 0.001 0.086 ± 0.004 48
09 0.755 ± 0.039 0.135 ± 0.006 0.114 ± 0.003 0.249 ± 0.010 44
d for Cr determination in real samples (N ¼ 7).
IICDET/CPeDLLME (mg L1)
CrIII Found CrVI Found Total
0.514 ± 0.026 0.221 ± 0.011 0.735 ± 0.032
0.996 ± 0.049 0.215 ± 0.010 1.211 ± 0.055
0.493 ± 0.023 0.705 ± 0.037 1.198 ± 0.059
HCT/IICDET/CPeDLLME (mg L¡1)
CrIII Found CrVI Found Total
0.072 ± 0.005 0.432 ± 0.025 0.504 ± 0.029
0.601 ± 0.036 0.426 ± 0.027 1.027 ± 0.058
0.068 ± 0.003 0.939 ± 0.022 1.007 ± 0.061
m serum) by ﬁltering, acid digestion by microwave and after spike with chromium
iological samples.
LOD RSD linear range PF/EF Sample volume Ref.
0.02 mg/L 2.6% e 83.5b 10 mL [40]
800 mg/L 2.6% 5e500 mg/L e 8.0 mL [41]
5.7 mg/L 1.1% 25e750 mg/L 20a 10 mL [42]
0.03 mg/L 4.7% 0.10e2.0 mg/L e 30 mL [43]
5.4 mg/L 9.8% 20- 500 mg/L 21.8b 2.1 mL [44]
0.006 mg/L 5.1% 0.03e0.13 mg/L 327b 10 mL [45]
0.056 mg/L 2.5% 2.0e160.0 mg/L 25a 25 mL [46]
od cells 0.005 mg/L 3.8% 0.02e1.75 mg/L 25.2a 5.0 mL This work
H. Shirkhanloo et al. / Analytical Chemistry Research 10 (2016) 18e2726analytical performances of detection of Cr achieved are comparable
to reported procedures (Table 7). Finally, the speciation chromium
in human biological samples based on IICDET/CP-DLLME with HCT
was revealed that the most of Cr(VI) and Cr(III) can exist in red
blood cells (RBC) and serum respectively. The IICDET/CP-DLLME
method was simply provide the concentration of Cr(III and VI) in
human blood cells and it is very important as a toxic and cancer
genic agent in human body (DNA-Cr-DNA).
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